Research Article
Austin J Clin Neurol 2017; 4(1): 1102.
Ethnic Differences in Association of Vitamin D Levels with Incident Stroke Cases between Ethnic Chinese and South Asians
De Silva DA¹*, Tan MSH², Allen JC Jr³, Ikram MK4, Wong TY4, Tan EK¹ and Lee WL5
¹Department of Neurology, National Neuroscience Institute, Singapore General Hospital Campus, Singapore
²Duke-NUS Graduate Medical School, Singapore
³Centre for Quantitative Medicine, Duke-NUS Graduate Medical School, Singapore
4Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
5National Neuroscience Institute, Tan Tock Seng Hospital Campus, Singapore
*Corresponding author: Deidre Anne De Silva, Department of Neurology, Singapore General Hospital, 20 College Road 169856, Singapore
Received: January 25, 2017; Accepted: March 13, 2017; Published: March 20, 2017
Abstract
Introduction: Published data suggests that vitamin D deficiency is associated with risk of coronary events and stroke mortality in whites but not in blacks. We aimed to investigate ethnicity interaction effects in the vitamin D-ischemic stroke relationship among ethnic Chinese and South Asians.
Materials & Methods: We recruited 271 ischemic stroke patients (87% Chinese, 13% South Asian, similar to the national ethnic distribution) with blood samples taken within 2 weeks of stroke onset to reflect pre-stroke levels, and 271 stroke-free controls matched for age, sex and ethnicity from populationbased studies. Serum 25-hydroxyvitamin D levels [25(OH)D] were measured by competitive electroluminescence immunoassay blinded to clinical data.
Results: Mean 25(OH)D levels were lower in South Asians than Chinese among stroke cases (19.1±8.4 vs. 24.6±9.3 ng/mL; P=0.001) as well as among controls (16.7±6.6 vs. 29.3±9.7 ng/mL; P<0.001). Among Chinese, 25(OH) D levels were significantly lower in stroke cases than in controls (P<0.001), however this was not the case among South Asians (P=0.188). There was an interaction between ethnicity with the association of 25(OH)D levels and stroke (P<0.001), which remained even after adjusting for covariates of diabetes, hypertension, hyperlipidemia, previous myocardial infarction and smoking status as well as calcium, phosphate and parathyroid hormone levels (P=0.003).
Conclusion: These data add to the evidence that the deleterious effects of vitamin D deficiency varies between ethnicities with differing skin pigmentation, with an association being found in ethnic Chinese, but not in ethnic South Asians.
Keywords: Vitamin D; Stroke; Asians; Ethnicity
Abbreviations
25(OH)D: 25-hydroxyvitamin-D; ANOVA: Analysis of Variance; CI: Confidence Interval; IQR: Interquartile Range; LSM: Least Squares Mean; PTH: Parathyroid Hormone; SAS: Statistical Analysis Systems; SD: Standard Deviation; TOAST: Trial of Org 10172 in Acute Stroke Treatment
Introduction
Ethnic differences have been reported in the association of vitamin D deficiency with its postulated deleterious effects including vascular risk [1-3]. Low vitamin D levels are associated with coronary heart events in whites but not blacks [1]. There are limited data on ethnic differences for stroke risk. One study showed a significant increased risk of fatal stroke with vitamin D deficiency among whites but not blacks [2]. Another used ethnic-specific tertile of vitamin D levels and found no influence of white versus black ethnicity on strength of association between vitamin D deficiency and incident stroke [4]. In Singapore, there are ethnic Chinese and South Asian populations who have lighter and darker skin pigmentation respectively as evidence by different melanin skin content [5]. We matched ischemic stroke patients with population-based controls among ethnic Chinese and ethnic South Asians (who have darker skin pigmentation and lower vitamin D levels [6]). Our aim was to investigate the effect of Chinese versus South Asian ethnicity on 25-hydroxyvitamin-D [25(OH) D] levels (ng/mL) in a comparison of stroke cases and controls, to explore the ischemic stroke-vitamin D relationship between these two ethnic groups.
Materials and Methods
We recruited 271 acute ischemic stroke patients each of Chinese and South Asian ethnicity admitted to two large tertiary hospitals in Singapore from July 2000 to September 2012. The study was approved by the institution review committees of both hospitals, and all subjects gave written informed consent. Stroke cases were matched on sex, race and age (within 5 years) to population-based controls with no previous self-reported history of stroke from two community-based epidemiological studies, the Singapore Chinese Eye Study (SCES) and the Singapore Indian Eye Study (SINDI) [7].
Ethnicity was ascertained during the patient interview or from the identification card issued to all Singapore citizens and residents. Ethnic South Asians are defined as people whose origin is from South Asian countries, namely India, Pakistan, Bangladesh, Nepal, Bhutan, Maldives and Sri Lanka [8]. Patients of mixed ethnicity were excluded. Stroke etiology was categorized by the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification [9]. Diabetes was defined as a self-reported history, use of diabetic medications or by the World Health Organization diagnostic guidelines [10], hypertension as a selfreported history, use of antihypertensive medication or by the Joint National Committee hypertension guidelines [11], hyperlipidemia as a self-reported history, use of lipid-lowering medication or by the National Cholesterol Education Program Adult Treatment Panel guidelines [12], previous myocardial infarction (MI) as a selfreported history and smoking as any history of smoking in the past or current smoking, For stroke cases, blood samples were taken within two weeks of stroke onset (median, 3 days; interquartile range [IQR], 2-5 days). Serum 25(OH)D was measured using competitive electro chemiluminescence protein binding immunoassay, employing a vitamin D binding protein as a capture protein with a Coefficient of Variance of 18.5% (Roche Diagnostics, Mannheim, Germany) [13] and was masked to clinical data. Serum calcium, phosphate and albumin were measured using colorimetric methods with ADVIA 2400 (Siemens Healthcare Diagnostics, NY, USA) and parathyroid hormone (PTH) measure using chemiluminometric two site sandwich assay (Siemens Healthcare Diagnostics, NY, USA).
Mixed model Analysis of Variance (ANOVA) was performed on 25(OH)D concentrations using the GLIMMIX procedure of the Statistical Analysis Systems (SAS) software package, version 9.3 (SAS Institute, Inc., Cary, NC). A two-factor unadjusted analysis model included main effects for ethnicity and group (case/control), and an ethnicity×group interaction. The same two-factor model augmented with available co variables was used in an adjusted analysis. In both analyses, matched pairs were incorporated as random subject effects. Subject effects and residual errors were assumed to be normally distributed. Statistical significance was declared for P values =0.05.
Results
The ethnic distribution for both stroke cases and controls was 87.5% Chinese (n=474, stroke=237, non-stroke=237) and 12.5% South Asian (n=68, stroke=34, non-stroke=34), similar to the national ethnic distribution in Singapore. The median age was 60 years (IQR 15) and 80% were male. The TOAST subtype distribution did not differ between ethnic Chinese patients (large vessel 14%, cardioembolic 10%, small vessel 46%, other etiology 1%, undetermined 29%) and ethnic South Asian (large vessel 21%, cardioembolic 6%, small vessel 41%, other etiology 3%, undetermined 29%) patients (P=0.389). Mean 25(OH)D levels were lower in South Asians than in Chinese for both stroke cases (19.1±8.4 vs. 24.6±9.3 ng/mL; P=0.001) and controls (16.7±6.6 vs. 29.3±9.7 ng/mL; P<0.001). In Chinese patients, the least squares mean (LSM) adjusted 25(OH)D concentration was lower in stroke cases than in controls (24.5 vs. 28.8 ng/mL, LSM difference -4.32; P<0.001); however, this was not the case in the South Asians (LSM difference 2.61; P=0.222) (Table 1). The ethnicity×group interaction was statistically significant in the unadjusted analysis (P=0.002) and persisted after adjustment for covariates of diabetes, hypertension, hyperlipidemia, previous myocardial infarction, smoking status, calcium, phosphate, and PTH levels (P=0.003).
Ethnicity
Study Group
Difference
(95% CI)
Difference
P Value
Ethnicity×Group Interaction
P Value*
Stroke
(n=271)
Control
(n=271)
Sample means†± SD
Chinese (n=474)
24.6 ± 9.3
(n=237)
29.3 ± 9.7
(n=237)
-4.63
(-6.23, -3.04)
<0.0001
0.002
South Asian (n=68)
19.1 ± 8.4
(n=34)
16.7 ± 6.6
(n=34)
2.44
(-1.77, 6.66)
0.255
Least squares means (95% CI) adjusted for covariables‡
Chinese (n=474)
24.5
(23.2, 25.8)
28.8
(27.4, 30.2)
-4.32
(-6.00, -2.65)
<0.0001
0.003
South Asian (n=68)
19.4
(16.3, 22.4)
16.8
(13.6, 19.9)
2.61
(-1.59, 6.81)
0.222
Abbreviations: CI: Confidence Interval; SD: Standard Deviation.
*Tests the null hypothesis that the differences between Stroke and Control groups are the same for both Chinese and South Asians.
†Same as ANOVA least squares means unadjusted for confounders.
‡P values: Group P=0.462, Ethnicity P<0.0001, age P<0.0001, diabetes P=0.222, hypertension P=0.523, hyperlipidemia P=0.184, previous myocardial infarction P=0.813, smoking status P=0.004, calcium P=0.120, phosphate P=0.483, and parathyroid hormone P=0.024.
Table 1: Mean 25-hydroxyvitamin-D levels (ng/mL) showing ethnicity×group interaction.
Discussion
This study found a significant ethnic interaction between low vitamin D levels and stroke between ethnic Chinese and ethnic South Asians. The vitamin D-stroke association in lighter-skinned Chinese but not in darker-skinned South Asians, is consistent with prior data for coronary disease and bone consequences [2,3]. The finding of lower vitamin D levels in ethnic Indians compared to Chinese is consistent with published literature [6] and may be contributed by darker skin pigmentation which reduces cutaneous vitamin D production [14].
The lack of vitamin D-stroke association in ethnic South Asians, which concurs with prior findings [15], may be due to adaptive mechanisms in vitamin D metabolism in darker-pigmented races [1]. Lower levels of vitamin D-binding proteins were observed in blacks versus whites which is postulated to provide protection against conditions associated with low levels of 25(OH)D [16]. Target organ effects of vitamin D deficiency may vary between races of differing skin pigmentation. It has been shown that there is skeletal resistance to PTH-stimulated bone resorption in blacks compare to whites [17].
Ethnicity should be an important consideration in studies investigating vascular risks of vitamin D deficiency. Emerging data show that low vitamin D is associated with poorer prognosis, including larger lesion volume [18], worse functional outcome [19,20] and poorer cognitive impairment [20] after stroke. Trials studying the benefits of vitamin D supplementation for vascular risk reduction and improving outcome after stroke should consider ethnicity as a confounding factor. Asians of differing skin pigmentations, such as Chinese and South Asians, should not be categorized together in such studies.
Strengths of this study include early blood sampling in stroke patients to reflect pre-stroke levels and obviate post-stroke confounders. There is likely no seasonal or latitude variations in vitamin D level in Singapore which is small and has uniform temperatures and hours of sunlight year-round. This is a case-control study and the demonstrated associations do not prove causality. Some potential 25(OH)D level confounders such as adiposity, dietary intake and vitamin supplementation were not considered. The proportion of cases by ethnicity (87% Chinese, 13% South Asian) in uneven, and is consistent with the general population in Singapore (74% Chinese, 9% South Asian) [21].
Conclusion
In conclusion, our study showed there was a vitamin D-stroke association in ethnic Chinese, but not in ethnic South Asians.
References
- Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013; 310: 179- 188.
- Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, et al. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition. 2012; 28: 367- 371.
- Gutiérrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011; 22: 1745-1753.
- Judd SE, Morgan CJ, Panwar B, Howard VJ, Wadley VG, Jenny NS, et al. Vitamin D deficiency and incident stroke risk in community-living black and white adults. Int J Stroke. 2016; 11: 93-102.
- Ginter JK, Krithika S, Gozdzik A, Hanwell H, Whiting S, Parra EJ. Vitamin D status of older adults of diverse ancestry living in the Greater Toronto Area. BMC Geriatr. 2013; 13: 66.
- Hawkins R. Total 25-OH vitamin D concentrations in Chinese, Malays and Indians. Ann Lab Med. 2013; 33: 156-158.
- Singapore Epidemiology of Eye Diseases (SEED). Singapore Eye Research Institute website.
- South Asian ethnic groups. Wikipedia website.
- Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke.1993; 24: 35-41.
- Alberti KG. Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional repot of a WHO consultation. Diabet Med. 1998; 15: 539- 553.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42: 1206-1252.
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program. JAMA. 2001; 285: 2486-2497.
- Cobas E411 Vitamin D Total Reagent Insert. Roche Diagnostics Web site.
- Correia A, Azevedo Mdo S, Gondim F, Bandeira F. Ethnic aspects of vitamin D deficiency. Arq Bras Endocrinol Metabol. 2014; 58: 540-544.
- Gupta A, Prabhakar S, Modi M, Bhadada SK, Lal V, Khurana D. Vitamin D status and risk of ischemic stroke in North Indian patients. Indian J Endocrinol Metab. 2014; 18: 721-725.
- Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369: 1991-2000.
- Harris SS. Vitamin D and African Americans. J Nutr. 2006; 136: 1126-1129.
- Turetsky A, Goddeau RP, Henninger N. Low serum Vitamin D is independently associated with larger lesion volumes after ischemic stroke. J Stroke Cerebrovasc Dis. 2015; 24: 1555-1563.
- Daumas A, Daubail B, Legris N, Jacquin-Piques A, Sensenbrenner B, Denimal D, et al. Association between admission serum 25-Hydroxyvitamin D levels and functional outcome of thrombolyzed stroke patients. J Stroke Cerebrovasc Dis. 2016; 25: 907-913.
- Yalbuzdag SA, Sarifakioglu B, Afsar SI, Celik C, Can A, Yegin T, et al. Is 25(OH)D associated with cognitive impairment and functional improvement in stroke? A retrospective clinical study. J Stroke Cerebrovasc Dis. 2015; 24: 1479-1486.
- Census of Population 2010 Statistical Release 1: Demographic Characteristics, Education, Language and Religion. Department of Statistics Singapore website.